# The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer

> **NCT04811079** · NA · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 53 (actual)

## Conditions studied

- Photosensitivity

## Interventions

- **OTHER:** 419 nm Spectacle Filter
- **OTHER:** 437 nm Spectacle Filter
- **OTHER:** 456 nm Spectacle Filter
- **OTHER:** 476 nm Spectacle Filter
- **OTHER:** 373 nm Spectacle Filter

## Key facts

- **NCT ID:** NCT04811079
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-14
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-16
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811079, "The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04811079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*